Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
11,216,419
-
Share change
-
+73,277
-
Total reported value
-
$90,850,834
-
Price per share
-
$8.10
-
Number of holders
-
42
-
Value change
-
+$922,705
-
Number of buys
-
15
-
Number of sells
-
22
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2017
As of 30 Sep 2017,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,216,419 shares.
The largest 10 holders included
FMR LLC, INTERWEST VENTURE MANAGEMENT CO, BB BIOTECH AG, FRAZIER MANAGEMENT LLC, Aisling Capital LLC, Broadfin Capital, LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Omega Fund Management, LLC, and Rock Springs Capital Management LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.